Product Information
INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PEN is a generic product labeled by Novo Nordisk, priced at $11.3904 per ML under NDC 73070040315. Its NADAC has been published 194 times since Jan 18, 2023.
Strength
100 U/mL
Manufacturer
Novo NordiskNDC
73070040315
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
5/20/2026
Active Ingredients
INSULIN DEGLUDECApproval Type
Biologic (BLA)
FDA Application
BLA203314On Market Since
7/1/2022
Pharmacological Classes
Price Statistics
The NADAC for INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PEN has been published 194 times since Jan 18, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.3904 per ML |
|---|---|
| All-time high | $11.4293 (Feb 14, 2024) |
| All-time low | $11.3292 (May 17, 2023) |
| 52-week high | $11.3904 |
| 52-week low | $11.3701 |
| Median price | $11.3778 |
| Average price | $11.3748 |
| Largest weekly change | -0.8% (Feb 21, 2024) |
| Weeks tracked | 194 |
| Tracking since | Jan 18, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Novo Nordisk manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
insulin degludec market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Insulin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PEN, manufactured by Novo Nordisk, is $11.3904 per ML (NDC 73070040315), effective Sep 30, 2026.
How has the price of INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PEN changed over time?
Over the history we have for it, the NADAC for INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PEN has held within roughly two percent of its current level. It has been tracked across 194 weekly CMS publications since Jan 18, 2023.
What are the highest and lowest recorded NADAC prices for INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PEN?
Since Jan 18, 2023, the NADAC for INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PEN has ranged from a low of $11.3292 (May 17, 2023) to a high of $11.4293 (Feb 14, 2024), with a median of $11.3778 per ML.
Are there cheaper alternatives to INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PEN?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRESIBA 100 UNIT/ML VIAL, is $9.0243 per ML — about 21% below INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PEN.
Who manufactures INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PEN?
INSULIN DEGLUDEC FLEXTOUCH 100 UNIT/ML PEN (NDC 73070040315) is labeled by Novo Nordisk, and CMS classifies it as a generic product.